GLP3-R is a triple agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Other Ingredients: Purified Water, Glycerin, Natural Flavor, Citric Acid, Xanthan Gum, Potassium Sorbate, and Evaporated Sea Water
Firstly, 80-90% of the secreted GLP-1 is degraded by the dipeptidyl-peptidase 4 (DPP-4) before reaching insulin secreting -cells
Understanding these mechanisms is essential when considering long-term treatment outcomes, as the body's response to these medications can evolve over time through various physiological adaptations
This contributes to a 2-4-fold increase risk in thrombosis and cardiovascular disease with cardiovascular disease accounting for 65% of the mortality rate in T2DM
While some patients notice a reduction in appetite within the first few weeks, meaningful improvements in blood sugar control and body weight typically become apparent after 8-12 weeks of consistent use